OS-01 (Peptide 14): Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข2 community protocols documented
- โขEvidence level: Anecdotal Reports
- โขBased on 200 community reports
- โข2 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Product Access | Clinical studies used standardized OS-01 formulations manufactured under controlled conditions with known peptide concentrations. | Consumers purchase OS-01 products directly from OneSkin's website or authorized retailers. The exact concentration of OS-01 peptide in commercial products is proprietary and not publicly disclosed. | low Unlike most peptides on this site, OS-01 is available as a commercial cosmetic product from a single manufacturer, reducing sourcing variability. |
| Expectations and Endpoints | Clinical studies measured specific biomarkers (p16INK4a expression, IL-8 levels, GlycanAge biological age) over defined timeframes using validated instruments. | Consumers evaluate OS-01 based on subjective visual appearance, skin texture, and feel. Some longevity-focused users track GlycanAge or other biological age markers independently. | moderate Subjective skin improvements may be influenced by the moisturizing base and other ingredients in OneSkin products, not solely the OS-01 peptide. |
Compare these community approaches with published research findings.
Community Protocols
Standard OneSkin Topical Protocol
Popular- Route
- Topical
- Dose
- Per product instructions (OS-01 FACE, OS-01 BODY, OS-01 EYE)
- Frequency
- Twice daily (morning and evening)
- Duration
- Ongoing (minimum 8-12 weeks recommended for visible results)
Applied to clean skin before moisturizer; OneSkin recommends consistent twice-daily use for at least 8 weeks
Targeted Anti-Aging Protocol
Common- Route
- Topical
- Dose
- OS-01 FACE + OS-01 EYE
- Frequency
- Twice daily
- Duration
- Ongoing
Combining face and eye products for comprehensive facial anti-aging; some users also add OS-01 BODY for neck and decolletage
Stacking Patterns
OS-01 + Retinol/Tretinoin
CommonCombined senomorphic and retinoid anti-aging
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 200+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/Longevity|OneSkin OS-01 experience threads(accessed 2026-02-18)
- Reddit r/SkincareAddiction|OneSkin product reviews and discussions(accessed 2026-02-18)
Community Evidence Overview#
OS-01 peptide has a unique position in the community landscape as the first senotherapeutic peptide available as a commercial consumer product (OneSkin). Community evidence is classified as anecdotal level, reflecting that most reports come from consumer product reviews rather than structured protocol reporting.
Unlike most peptides discussed on this site, OS-01 is not available as a raw research peptide. It is exclusively available through OneSkin's commercial skincare line (OS-01 FACE, OS-01 BODY, OS-01 EYE). This means community usage is more standardized than typical peptides, as all users are using the same commercial formulations.
Protocol Divergence#
Protocol divergence for OS-01 is minimal compared to other peptides on this site. The primary divergence involves expectations: clinical studies measured specific biomarkers (p16INK4a expression, IL-8 levels, biological age markers) over defined timeframes, while consumers evaluate results based on subjective visual appearance. Some longevity-focused community members do track biological age markers (GlycanAge) to assess OS-01 effects, but this is a small minority.
Community Protocols#
The standard protocol follows OneSkin's product instructions: apply twice daily to clean skin, before moisturizer. Community consensus suggests allowing 8-12 weeks of consistent use before evaluating results, consistent with the timeline of published clinical studies.
Commonly Reported Outcomes#
Consumer reports commonly describe:
- Improved skin texture and smoothness (frequently reported after 4-8 weeks)
- Subtle improvements in fine lines (reported after 8-12 weeks)
- Good product feel and absorption (consistent feedback)
- No irritation or adverse reactions (consistent with clinical safety data)
- Results described as subtle and gradual rather than dramatic
Important Caveats#
- OS-01 is a cosmetic product, not an FDA-approved drug
- The exact OS-01 peptide concentration in commercial products is proprietary
- Subjective skin improvements may be partly attributable to the moisturizing base formulation
- All published clinical studies are industry-sponsored (OneSkin/Proven Skincare)
- Long-term effects beyond the study durations (12 weeks) have not been formally evaluated
- OS-01 is a senomorphic (modulates senescent cells) not a senolytic (kills senescent cells) โ community sometimes conflates these terms
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.